Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2026-05-21 @ 10:08 AM
Study NCT ID:
NCT00996567
Status:
COMPLETED
Last Update Posted:
2017-02-09
First Post:
2009-10-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.
Sponsor:
University Hospital, Ghent
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2009/337
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |